drug in Biological Technology
Navigation Links
drug in Biological Technology
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
... of Health ("NIH"), the National Institute on drug Abuse, and other agencies that operate under the ... "Fast Track" status by the U.S. Food & drug Administration (FDA) for the treatment of cocaine ... the clinical trials required for us to file a new drug application for CPP-109, our ability to complete ...NeurogesX Reports Second Quarter 2009 Results
... topical anesthetic Announced FDA orphan drug designation for Qutenza in PHN Added to ... for data and analyses as part of the ongoing new drug application (NDA) review for Qutenza in ... In the United States, NeurogesX submitted a new drug application (NDA) for PHN to the Food ...Viral Genetics Creates Subsidiary to Develop Cancer Therapy
... therapies, is very promising for combating drug resistant tumors," said Dr. Newell. Prior ... holds tremendous hope for patients with drug resistant tumors," said Haig Keledjian, CEO of ... California, Viral Genetics discovers and develops drug therapies to treat infectious, autoimmune, and ...Synthetech Reports First Quarter Fiscal 2010 Results
... and revenues. As the uncertainties inherent in drug development projects remain outside of ... ( cGMP ) in compliance with U.S. Food and drug Administration ( FDA ) regulations. Our products ... base includes major pharmaceutical, contract drug synthesis firms, emerging biotechnology (virtual ...Telik Announces Second Quarter 2009 Financial Results
... Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and ... The company's most advanced investigational drug candidates in clinical development are ... candidates were discovered using its proprietary drug discovery technology, TRAP(R), which enables the ...... -- New therapeutics funded by the Alzheimer's drug Discovery Foundation (ADDF) , have achieved a ... only public charity whose sole mission is to fund drug discovery and development to prevent, treat, and ... cells and that had profiles suitable for further drug development. Once these molecules were ...
Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
... /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS ), a drug development company focused on developing ... clinical development plan for our novel drug candidate, CUDC-305, which we believe may offer ... pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs. ...... and anti-infection, Omnio Healer is developing drug candidates with potent pro-inflammatory ... Healer AB is a pioneer company developing novel drug candidates based on a series of conceptual ... healing and anti-infection. The company's lead drug candidate, aimed primarily at otological ...
... TAXUS(R) coronary stent systems incorporating the drug paclitaxel. TAXUS stents have been evaluated by ... we announced that the United States Food and drug Administration ("FDA") had granted 510(k) ... research and development and product and drug development. Such forward-looking statements ...
NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
... today announced that the United States Food and drug Administration (FDA) has extended the Prescription drug User Fee Act (PDUFA) date from August 16, 2009 to November 16, 2009 to review the new drug application (NDA) for Qutenza(TM) to manage pain ...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... Company reached agreement with the U.S. Food and drug Administration (FDA) on the key protocol design ... 2 clinical trial of the Company's investigational drug Plicera is ongoing. This 6-month study is ... the Phase 2 clinical trial of its investigational drug AT2220 for the treatment of Pompe Disease and ...Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
... second quarter of 2009, Cadence submitted its New drug Application (NDA) for Acetavance(TM) (intravenous ... NDA of November 13, 2009 under the Prescription drug User Fee Act (PDUFA). "We are very ... of the NDA; the risk that increased attention to drug safety issues in general may result in a more ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... for the product. Rolling review of the New drug Application ("NDA") has started. Our core ... of oppositional symptoms. - The Prescription drug User Fee Act date ("PDUFA") for INTUNIV was July ... was also found to be well tolerated with no drug related serious adverse events reported in ...Next Safety Releases Advanced Respirator for Infectious Diseases
... The company also develops pulmonary drug delivery products. It is a leader in the ... Next Safety is also developing other pulmonary drug delivery platforms for inhaled antibiotics and ... is developing combined respirator and pulmonary drug delivery systems for soldiers to have highly ...... designed in collaboration with the U.S. Food and drug Administration (FDA), and evaluated the cardiac ... be incorporated into picoplatin's rolling New drug Application (NDA) filing, which the Company plans ... business objectives and strategic goals, drug development plans, the potential safety and ...
Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
... oncologist who brings an extensive background in drug development to her new role at Oncothyreon," said ... leadership and knowledge of all aspects of cancer drug development will be very important as we prepare ... target at the forefront of current cancer drug research." Dr. Hausman joins Oncothyreon from ...... Development of the United States Food and drug Administration (FDA) has granted Orphan drug Designation to Oral BDP (beclomethasone ... cell transplantation. The US Orphan drug Act is intended to assist and encourage companies ...
Biotech Hot in July Driven by Positive Drug Data and Acquisitions
... -- Biotech was "hot" in July driven by drug data, positive drug sales/earnings and partnering and M&A deals. ... results for its experimental lupus injectable drug Benlysta, confounding all analysts' expectations ...... has reached an agreement with the U.S. Food and drug Administration (FDA) regarding a Special Protocol ... This represents a major milestone in our oncology drug development strategy which could hold great ... that are intended to form the basis for a new drug application. Final marketing approval depends ...
... United States. If approved by the U.S. Food and drug Administration (FDA), Intermezzo ((R)) has the ... established October 30, 2009 as the Prescription drug User Fee Act (PDUFA) action date for the Intermezzo ((R)) New drug Application (NDA). In the agreement ...
... response letter today from the U.S. Food and drug Administration (FDA) regarding its New drug Application (NDA) for Restanza(TM) (cethromycin) ... of CAP. The committee's negative vote on the drug candidate's efficacy followed a discussion that ...
NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
... In the United States, NeurogesX submitted a new drug application (NDA) for PHN to the U.S. Food and drug Administration (FDA) which was accepted for ... FDA in December 2008 and was given a Prescription drug User Fee Act (PDUFA) date of August 16, 2009. ...R-Tech Ueno Notifies R&D Items
... eyedrop 0.12%" that is marketed as a therapeutic drug for glaucoma and ocular hypertension. This drug is now being developed by R-Tech Ueno for the indication of retinitis pigmentosa. The drug is introduced to Sucampo Pharma Americas Ltd. in ...Stemline Therapeutics CEO to Present at IBC's New Frontiers in Cancer Drug Development Conference
... invited to present at the New Frontiers in Cancer drug Development conference which is part of IBC's drug Discovery and Development Week in Boston, MA. Dr. Bergstein's presentation, entitled "Developing drug Candidates Directed to Cancer Stem Cell Targets: ...... of the antibiotic amikacin, which encloses the drug in nanocapsules of lipid called liposomes. This ... ARIKACE has been granted orphan drug status in the United States by the FDA, and has received an orphan drug designation in Europe by the European Medicines ...
Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
... evaluation approved by the State Food and drug Administration in 2009. ... is a modified controlled-release antidiabetic drug to treat type 2 diabetes. The market size of ... (1) Source: CHINA ANTI-DIABETIC drug MARKET REPORT prepared by Life Science ...... MSM Protein Technologies (MSM), a human antibody drug discovery company with world class expertise in ... expertise, together with our experience in drug development should lead to innovative ... pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs. ...
... of Homspera resulted in measurable amounts of the drug in lung tissue. Systemic absorption and ... development and licensing of the potential drug candidate Homspera and its derivatives Radilex(R) ... Management is focused on the development of these drug candidates as potential treatments for blood ...
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
... whom have tremendous track records for advancing drug pipelines, leading pharmaceutical and life ... FDA approval for Tetrabenazine (TBZ), the first drug ever licensed in the United States to treat ... 2a data for a novel first in class antiepileptic drug that will address unmet medical needs for adults ...... in these countries. Amgen will commercialize the drug for PMO and oncology in the United States (U.S.) ... more effectively than if we commercialized the drug globally on our own," said Amgen CEO Kevin ... candidates are not approved by the U.S. Food and drug Administration (FDA) or other regulatory bodies, ...
... a novel, orally administered investigational new drug that is designed to selectively block ... NF2, building upon ongoing evaluations of the drug in patients with metastatic breast cancer, ... proprietary technologies that it applies in its drug discovery activities have been the basis for ...
PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
... Yeda a license to develop a number of peptide drug candidates, including an anti-obesity peptide, ... president of PROLOR. "The first preclinical drug candidate we will evaluate under the agreement is ... for us to explore entering this market with a drug candidate that may have strong competitive ...... 3D Structure Prediction to Improve and Accelerate drug Discovery The genomics era has produced a ... target for structural prediction and future drug development, including antibiotics for pathogenic bacteria that have developed drug resistance. DNA Software has a breakthrough ...
Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International
... differentiate into essential cell types for drug discovery and development and eventually ... neural cells, etc.) derived from iPS cells for drug development. This progress has been highlighted ... towards personalized therapeutics. In vitro drug testing can be severely limited by the lack of ...... for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, ... technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated ...
A drug-dispensing contact lens
... director of the Laboratory for Biomaterials and drug Delivery at Children's Hospital Boston, have ... amounts of drug; typically, a burst of drug is delivered in the first few hours, followed by ... already approved for ocular use by the Food and drug Administration. In laboratory testing, the ...... it has received approval from the U.S. Food and drug Administration (FDA) for its New drug Application (NDA) for Sumavel DosePro ... system could transform the future of subcutaneous drug delivery of pharmaceuticals. This first approval ...
... compound, is the first agent in Champions' drug development pipeline. Using Neowater((R)), a ... nearly a year of efforts to build our oncology drug pipeline we expect to in-license additional drugs ... path for the compound in terms of indication, drug combination, and target patient populations. ...
Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
... a rich pipeline of next-generation antiviral drug candidates, productive platform technology, an ... necessary to emerge at the forefront of antiviral drug development," said Mr. Moch. "I am excited to ... lipid technology, Chimerix is able to develop drug candidates with oral availability or topical ...UCSF researchers help crack parasite genome, identify drug leads
... other biomedical contexts has provided valuable drug targets. Findings are published in the July 16, ... of Quantitative Biosciences (QB3). Just one drug is currently widely available to treat ... say poses the risk of encouraging the parasite's drug resistance as aid organizations extend the ...Other ContentsaccidentsaccidentsaccidentsaceacetaminophenacetaminophenachalasiaacetoneachondroplasiaOther TagsPersistEmphasize
(Date:12/14/2009)... tool use as a defining feature of humans. That,s until ... with birds and an array of other mammals. Now, a ... , a Cell Press publication, adds an octopus to the ... study manages a behavioral trick that the researchers call stilt ... upright coconut shell "bowls," makes its eight arms rigid, and ...
(Date:12/13/2009)... Biologists have identified plant enzymes that may help to ... to use water more efficiently. The finding could help ... gases. , Plants take in the carbon dioxide they ... surface of leaves. But for each molecule of the ... these same openings. The pores can tighten to save ...
(Date:12/13/2009)... Scripps Research Institute have solved a 10-year-old mystery ... family of enzymes can have two completely distinct ... guidance for understanding other molecules in the family, ... protein,s possible use for combating diseases including cancer ... in the December 13, 2009 advance, online issue ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 1Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 2Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 3Health Care Retail Clinics Continue Gradual Expansion Through 2012 3A Deloitte Center for Health Solutions Report 6288 4Brookstone Pharmaceuticals LLC becomes Acella Pharmaceuticals LLC 6284 1Child Food Allergies on the Rise in U S 61410 1Child Food Allergies on the Rise in U S 61410 2Child Food Allergies on the Rise in U S 61410 3(Date:12/15/2009)... -- The new compact LifeSpan TR200 folding treadmill, made ... ), was highly praised by treadmill review groups in ... compact TR200 folding treadmill received awards for Best New ... ,, The compact LifeSpan TR200 treadmill is designed ... "This category buster is a very compact treadmill that ...
(Date:12/15/2009)... of 30 Individuals Charged in Miami, Detroit and ... Billing to Medicare ,, WASHINGTON, Dec. ... in three cities for their alleged roles in ... false Medicare claims as part of the continuing ... of Health and Human Services (HHS) Secretary Kathleen ...
(Date:12/15/2009)... chronic obstructive pulmonary disease, or COPD, with increased activity ... body,s immune system. , The University of Michigan ... the immune system,s role in COPD, a serious, progressive ... with wheezing, shortness of breath, chest tightening and other ... to find better ways to detect and treat the ...
(Date:12/15/2009)... decade, the United Nations Foundation has led the fight ... World Malaria Report 2009 that the global strategies for ending malaria ... Health for the United Nations Foundation , ... Washington, ... United Nations Foundation has led the fight against malaria, ...
(Date:12/15/2009)... changes increases risk in teens, study suggests , , TUESDAY, ... or obese increases the risk of obstructive sleep apnea, ... for younger children, Australian researchers have found. , In ... to 18, who were referred for evaluation of snoring ... among those aged 12 and older the risk of ...
Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2[0] Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill[1] Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La.[1] Immune cell activity linked to worsening COPD[0] Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009[0] Puberty May Trigger Sleep Apnea in Overweight Kids
SermonsCoinfectionPersistKleptomaniaRecruitedMineworkersLitigationTyresOlivesEmphasizeAugmentsWaterAidGlucocorticoidsTumorous
Other Tagslacking 2lacking 3lacking 4lacking 5lacking 6lacking 7lacking 8limiting 2limiting 3limiting 4limiting 5limiting 6limiting 7choice 2choice 3choice 4choice 5choice 6choice 7choice 8choice 9choice 10preferred 2preferred 3preferred 4preferred 5preferred 6preferred 7preferred 8gained 2gained 3gained 4gained 5ill 2critically 2critically 3critically 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |